Arşiv logosu
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
Arşiv logosu
  • Koleksiyonlar
  • DSpace İçeriği
  • Analiz
  • Talep/Soru
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
  1. Ana Sayfa
  2. Yazara Göre Listele

Yazar "Caglayan, D." seçeneğine göre listele

Listeleniyor 1 - 5 / 5
Sayfa Başına Sonuç
Sıralama seçenekleri
  • Küçük Resim Yok
    Öğe
    18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Maximum Standardized Uptake Value (SUVmax) as a Prognostic Factor in Adult Hodgkin Lymphoma Patients
    (Elsevier Science Inc, 2013) Adli, M.; Caglayan, D.; Koc, M.; Zincirkeser, S.; Turk, H. M.
    [Abstract Not Availabe]
  • Küçük Resim Yok
    Öğe
    18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Maximum Standardized Uptake Value (SUVmax) as a Prognostic Factor in Non-Hodgkin Lymphoma Patients
    (Elsevier Science Inc, 2013) Adli, M.; Caglayan, D.; Koc, M.; Zincirkeser, S.; Turk, H. M.
    [Abstract Not Availabe]
  • Küçük Resim Yok
    Öğe
    18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Maximum Standardized Uptake Value (SUVmax) as a Prognostic Factor in Pediatric Hodgkin Lymphoma Patients
    (Elsevier Science Inc, 2013) Adli, M.; Caglayan, D.; Koc, M.; Zincirkeser, S.; Guler, E.
    [Abstract Not Availabe]
  • Küçük Resim Yok
    Öğe
    Evaluating the effect of tumor size and sidedness on prognosis in stage 2 colon cancer: a retrospective population study
    (Verduci Publisher, 2022) Demir, H.; Caglayan, D.; Kaman, O.; Inanc, M.; Urvay, S.; Beypinar, I; Demirci, A.
    OBJECTIVE: In this study. we aimed to evaluate the effect of tumor size and tumor sidedness on prognosis in patients with stage 2 colon cancer. PATIENTS AND METHODS: Data of 501 patients diagnosed with stage 2 colon cancer were evaluated retrospectively. It was evaluated whether the patients' age, gender, tumor differentiation, tumor node metastasis (TNM) stage, overall survival rate, and disease-free survival rate had any correlation with horizontal tumor diameter and tumor sidedness. In the ROC analysis performed to determine the cut-off value for the tumor diameter, which we think will predict survival, no significant results were obtained with maximum sensitivity and specificity. Therefore, the median value of the tumor diameter, which is 5 cm, was accepted as the cut-off value. Kaplan-Meier method and Cox regression analysis were used for survival analysis and determination of prognostic factors. RESULTS: When the patients were evaluated in terms of tumor localization, 189 (37.7%) patients had right colon tumors and 312 (62.3%) patients had left colon tumors. There was no statistically significant difference in terms of disease-free survival and overall survival according to tumor localization. When the patients were analyzed by dividing them into two groups according to the horizontal tumor size (<5 cm and >= 5 cm), no statistically significant difference was found between the groups in terms of disease-free survival (DFS) and overall survival (OS) p=0.085, p=0.699, respectively. CONCLUSIONS: Our results suggest that the management of patients with stage 2 colon cancer requires a better understanding of tumor biology rather than features such as tumor size and localization.
  • Küçük Resim Yok
    Öğe
    The impact of body mass index (BMI) on the progression-free survival of CDK4/6 inhibitors in metastatic breast cancer patients (MBC)
    (Elsevier, 2022) Artac, M.; Caglayan, D.; Kocak, M. Z.; Geredeli, C.; Tatli, A. M.; Goksu, S. Sezgin; Imaz, M. Karakurt Ery
    [Abstract Not Availabe]

| Necmettin Erbakan Üniversitesi | Kütüphane | Açık Erişim Politikası | Rehber | OAI-PMH |

Bu site Creative Commons Alıntı-Gayri Ticari-Türetilemez 4.0 Uluslararası Lisansı ile korunmaktadır.


Yaka Mahallesi, Yeni Meram Caddesi, Kasım Halife Sokak, No: 11/1 42090 - Meram, Konya, TÜRKİYE
İçerikte herhangi bir hata görürseniz lütfen bize bildirin

DSpace 7.6.1, Powered by İdeal DSpace

DSpace yazılımı telif hakkı © 2002-2025 LYRASIS

  • Çerez ayarları
  • Gizlilik politikası
  • Son Kullanıcı Sözleşmesi
  • Geri bildirim Gönder